CLARITIN REDITABS 24-HOUR OTC
Generic Name and Formulations:
Loratadine 10mg; orally-disintegrating tabs; mint flavor.
Merck & Co., Inc.
Indications for CLARITIN REDITABS 24-HOUR:
Allergic rhinitis (seasonal).
Adults and Children:
<2yrs: not recommended. 2–5yrs: 5mg once daily. ≥6yrs: 10mg once daily or 5mg twice daily. Hepatic or renal insufficiency: see literature. RediTabs: dissolve on tongue; swallow with or without water. Liqui-Gels: swallow whole.
Hives Relief: not a substitute for epinephrine. Pregnancy. Nursing mothers.
Adults: headache, somnolence, fatigue, dry mouth. Children: nervousness, wheezing, hyperkinesia, abdominal pain, conjunctivitis, dysphonia, malaise, upper respiratory infections.
Tabs—10, 20, 30; RediTabs 24-Hour—10, 20; RediTabs 12-Hour—10, 30; Liqui-Gels—10, 24, 40; Chewables—5, 10; Syrup—4oz; Hives Relief—10, 30
Endocrinology Advisor Articles
- Higher BUN May Increase Risk for Incident Diabetes
- Efficacy of Novel GLP-1 Receptor Agonist Drug Device Examined
- Takeout Food May Increase Adverse Health Consequences in Children
- Nonhormonal Options Available for Menopause Symptom Relief
- Plasma Volume Changes Mediate Risk of CV Mortality With Empagliflozin
- New Consensus Recommendations on Use of Continuous Glucose Monitoring
- Does Genetic Susceptibility Lead to Late-Onset Type 1 Diabetes?
- Clinical Outcomes in T2D: Low-Carbohydrate vs Calorie-Restricted Diet
- New Continuous Glucose Monitoring System Now Available for Medicare Patients
- Text Message-Delivered Interventions Effective for Weight Management
- Effect of Intra-Articular Depot Betamethasone on Insulin Resistance in T2D
- Gastric Bypass vs Sleeve Gastrectomy Outcomes in Morbid Obesity
- Acute Kidney Injury Increases Risk for Postdischarge Hypoglycemia in Diabetes
- Novel Deep Learning System May Help Identify Diabetic Retinopathy
- Trends in CVD, Risk Factors, and Medications in Children With T1D